CancerDrs

Multiple Myeloma

Plasma cell malignancy. Trials test CAR-T, bispecific antibodies, and combination regimens in newly diagnosed and relapsed/refractory settings.

62.4%
5-year relative survival
U.S. average across all stages
265
recruiting trials
Active in the U.S. right now
36,110
new diagnoses / year
You are not alone — roughly 99 people per day
69
median age at diagnosis
Most diagnoses occur in adults over age 50

Source: NCI SEER + ClinicalTrials.gov

Multiple Myeloma by the numbers (U.S.)

36,110
Estimated new cases (2025)
12,030
Estimated deaths (2025)
62.4%
5-year relative survival
69
Median age at diagnosis

Source: NCI SEER Cancer Stat Facts

Multiple Myeloma clinical trials →

265 actively recruiting trials across the U.S., with filters by state.

Second opinion for multiple myeloma →

Step-by-step for getting a virtual second opinion from a top cancer center.

NCI-designated cancer centers →

All 71 NCI cancer centers with hospital quality data and state browser.

Find a medical oncologist →

Licensed oncologists across every U.S. state, by specialty.

Financial aid resources →

Co-pay relief, drug patient-assistance, transportation, and lodging support.

Patient guides →

How to read a pathology report, questions to ask your oncologist, staging explained.

Also known as

myeloma, plasma cell myeloma.

For deeper statistics

See the NCI SEER Cancer Stat Facts page: Multiple Myeloma on SEER →